Scott L. Burrows, CFO: Spyre Therapeutics SYRE Sell · Filed 06/26

Trade details

Type: Insider sale
Amount: $435,600
Shares · price: 5,000 sh · $87.12 a share
Held after: 107,994 sh
Stock: Spyre Therapeutics SYRE
Person: Scott L. BurrowsCFO
Trade date: 26/06/25
Filed: 26/06/26
Days to filing: 1 days

Sold 4.4% of holdings

Share of holding sold: 4.4%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 05/26~07/25

Scott L. Burrows's recent trades

Scott L. BurrowsCFO
Planned saleSpyre Therapeutics
Planned sale
Spyre Therapeutics
SYRE
$1.6M
17,500 sh
$1.6M
Filed 09/30
Traded 09/30
Scott L. BurrowsCFO
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$2.9M
30,000 sh
$2.9M
Filed 08/03
Traded 08/03
Scott L. BurrowsCFO
SellSpyre Therapeutics
Sell
Spyre Therapeutics
SYRE
$871.4K
10,000 sh
$871.4K
Filed 06/26
Traded 06/25
Scott L. BurrowsCFO
Planned saleSpyre Therapeutics
Planned sale
Spyre Therapeutics
SYRE
$1.3M
15,000 sh
$1.3M
Filed 06/25
Traded 06/25
Scott L. BurrowsCFO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$223.4K
3,100 sh
$223.4K
Filed 06/03
Traded 06/01